Syringes

International pharmaceutical corporation Pfizer opted for Schreiner MediPharm’s Needle-Trap needle protection label to equip the syringes for its epoetin biosimilar. This makes it the first medication for the treatment of anemia to be launched on the market with Needle-Trap–initially in Germany and Austria, to be followed by a successive rollout on the European market.

 

Privacy Policy